kn-93 and Asthma

kn-93 has been researched along with Asthma* in 2 studies

Other Studies

2 other study(ies) available for kn-93 and Asthma

ArticleYear
Oxidized CaMKII promotes asthma through the activation of mast cells.
    JCI insight, 2017, 01-12, Volume: 2, Issue:1

    Oxidation of calmodulin-dependent protein kinase II (ox-CaMKII) by ROS has been associated with asthma. However, the contribution of ox-CaMKII to the development of asthma remains to be fully characterized. Here, we tested the effect of ox-CaMKII on IgE-mediated mast cell activation in an allergen-induced mouse model of asthma using oxidant-resistant CaMKII MMVVδ knockin (MMVVδ) mice. Compared with WT mice, the allergen-challenged MMVVδ mice displayed less airway hyperresponsiveness (AHR) and inflammation. These MMVVδ mice exhibited reduced levels of ROS and diminished recruitment of mast cells to the lungs. OVA-activated bone marrow-derived mast cells (BMMCs) from MMVVδ mice showed a significant inhibition of ROS and ox-CaMKII expression. ROS generation was dependent on intracellular Ca

    Topics: Animals; Asthma; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Hypersensitivity, Immediate; Inflammation; Lung; Mast Cells; Mice; Protein Kinase Inhibitors; Respiratory Hypersensitivity; Sulfonamides

2017
CaMKII is essential for the proasthmatic effects of oxidation.
    Science translational medicine, 2013, Jul-24, Volume: 5, Issue:195

    Increased reactive oxygen species (ROS) contribute to asthma, but little is known about the molecular mechanisms connecting increased ROS with characteristic features of asthma. We show that enhanced oxidative activation of the Ca(2+)/calmodulin-dependent protein kinase (ox-CaMKII) in bronchial epithelium positively correlates with asthma severity and that epithelial ox-CaMKII increases in response to inhaled allergens in patients. We used mouse models of allergic airway disease induced by ovalbumin (OVA) or Aspergillus fumigatus (Asp) and found that bronchial epithelial ox-CaMKII was required to increase a ROS- and picrotoxin-sensitive Cl(-) current (ICl) and MUC5AC expression, upstream events in asthma progression. Allergen challenge increased epithelial ROS by activating NADPH oxidases. Mice lacking functional NADPH oxidases due to knockout of p47 and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and airway hyperreactivity to inhaled methacholine. Our findings support the view that CaMKII is a ROS-responsive, pluripotent proasthmatic signal and provide proof-of-concept evidence that CaMKII is a therapeutic target in asthma.

    Topics: Administration, Intranasal; Animals; Asthma; Benzylamines; Blotting, Western; Bronchi; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Female; Humans; In Vitro Techniques; Male; Mice; NADPH Oxidases; Ovalbumin; Oxidation-Reduction; Protein Kinase Inhibitors; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Sulfonamides

2013